Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Journals Blog

  • Visit AAP News on Facebook
  • Follow AAP News on Twitter

Anchoring on Multisystem Inflammatory Syndrome in Children

Alan R. Schroeder, MD, Associate Editor, Hospital Pediatrics
January 11, 2021

For many of us in the inpatient and emergency department world, multisystem inflammatory syndrome in children (MIS-C) has taken center stage in our clinical lives. Because the condition is new, vague, and still being defined, we entertain the diagnosis for a wide range of signs and symptoms. Children with common complaints such as abdominal pain and fever are now getting an array of diagnostic tests to assess for inflammation and myocardial injury/dysfunction.

The CDC has established criteria for diagnosis, but these criteria are, admittedly, fairly non-specific. One important criterion is that the patient has “no alternative plausible diagnoses,” which introduces even more uncertainty. Does a positive throat culture count, especially given that a substantial proportion of children are colonized with Group A Streptococcus? What about rhinovirus from a respiratory panel?

The heightened emphasis on MIS-C has two immediate risks: one, excessive testing and treatment are provided for patients who don’t have the condition, and two, diagnosis and treatment of other conditions may be delayed or missed altogether. Two articles released by Hospital Pediatrics highlight the latter concern.

The first article by Molloy et al (10.1542/hpeds.2020-005579) is part of our Bending the Value Curve series and involves a patient with persistent fever and pyuria on a urinalysis. Because this finding has been described in Kawasaki disease (which overlaps considerably with MIS-C), an extensive workup for MIS-C was initiated and the patient was not treated initially for pyelonephritis. The urine culture resulted positive the next day.

Dean et al (10.1542/hpeds.2020-005652) report a case series of five patients who were hospitalized with signs and symptoms consistent with MIS-C and underwent extensive workup for that condition. One patient received intravenous immunoglobulin. All five were ultimately diagnosed and treated for murine typhus.

Anchoring and misdiagnosis are not new phenomena in pediatric medicine. But the combination of the high prevalence of COVID-19, the flurry of attention over MIS-C, and the concern about “missing” a potentially serious condition have greatly increased the likelihood that premature closure will occur. Kids are still getting sick for other reasons, and these cases remind us to keep our differentials broad and proceed in a methodical, stepwise fashion.

  • COVID-19 in Pediatrics: Characteristics of Hospitalized Children in New Jersey
  • COVID-19 and Kawasaki Disease: Finding the Signal in the Noise
  • Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area
  • Facebook
  • Instagram
Copyright © 2021 American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Share
Anchoring on Multisystem Inflammatory Syndrome in Children
Alan R. Schroeder, MD
January 11, 2021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Email Blog Post

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anchoring on Multisystem Inflammatory Syndrome in Children
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics